This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wherry, E. J.
Right arrow Articles by Ahmed, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wherry, E. J.
Right arrow Articles by Ahmed, R.

 Previous Article  |  Next Article 

Journal of Virology, July 2005, p. 8960-8968, Vol. 79, No. 14
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.14.8960-8968.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Low CD8 T-Cell Proliferative Potential and High Viral Load Limit the Effectiveness of Therapeutic Vaccination

E. John Wherry,1* Joseph N. Blattman,2 and Rafi Ahmed1*

Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, 1510 Clifton Road, Room G211, Atlanta, Georgia 30322,1 Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, P. O. Box 19024, D3-100, Seattle, WA 98109-10242

Received 28 December 2004/ Accepted 17 March 2005

Therapeutic vaccination has the potential to boost immune responses and enhance viral control during chronic infections. However, many therapeutic vaccination approaches have fallen short of expectations, and effective boosting of antiviral T-cell responses is not always observed. To examine these issues, we studied the impact of therapeutic vaccination, using a murine model of chronic infection with lymphocytic choriomeningitis virus (LCMV). Our results demonstrate that therapeutic vaccination using a recombinant vaccinia virus expressing the LCMV GP33 CD8 T-cell epitope can be effective at accelerating viral control. However, mice with lower viral loads at the time of vaccination responded better to therapeutic vaccination than did those with high viral loads. Also, the proliferative potential of GP33-specific CD8 T cells from chronically infected mice was substantially lower than that of GP33-specific memory CD8 T cells from mice with immunity to LCMV, suggesting that poor T-cell expansion may be an important reason for suboptimal responses to therapeutic vaccination. Thus, our results highlight the potential positive effects of therapeutic vaccination on viral control during chronic infection but also provide evidence that a high viral load at the time of vaccination and the low proliferative potential of responding T cells are likely to limit the effectiveness of therapeutic vaccination.


* Corresponding author. Mailing address for R. Ahmed: Emory Vaccine Center, Emory University School of Medicine, 1510 Clifton Road, Room G211, Atlanta, GA 30322. Phone: (404) 727-4700. Fax: (404) 727-3722. E-mail: ra{at}microbio.emory.edu. Present address for E. J. Wherry: Immunology Program, The Wistar Institute, 3601 Spruce Street, Room 251, Philadelphia, PA 19104. Phone: (215) 495-6825. Fax: (215) 495-6817. E-mail: jwherry{at}wistar.upenn.edu.


Journal of Virology, July 2005, p. 8960-8968, Vol. 79, No. 14
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.14.8960-8968.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Manuel, S. L., Schell, T. D., Acheampong, E., Rahman, S., Khan, Z. K., Jain, P. (2009). Presentation of human T cell leukemia virus type 1 (HTLV-1) Tax protein by dendritic cells: the underlying mechanism of HTLV-1-associated neuroinflammatory disease. J. Leukoc. Biol. 86: 1205-1216 [Abstract] [Full Text]  
  • Takagi, A., Matsui, M., Ohno, S., Duan, H., Moriya, O., Kobayashi, N., Oda, H., Mori, M., Kobayashi, A., Taneichi, M., Uchida, T., Akatsuka, T. (2009). Highly Efficient Antiviral CD8+ T-Cell Induction by Peptides Coupled to the Surfaces of Liposomes. CVI 16: 1383-1392 [Abstract] [Full Text]  
  • Cush, S. S., Flano, E. (2009). Protective Antigen-Independent CD8 T Cell Memory Is Maintained during {gamma}-Herpesvirus Persistence. J. Immunol. 182: 3995-4004 [Abstract] [Full Text]  
  • Oestreich, K. J., Yoon, H., Ahmed, R., Boss, J. M. (2008). NFATc1 Regulates PD-1 Expression upon T Cell Activation. J. Immunol. 181: 4832-4839 [Abstract] [Full Text]  
  • Blackburn, S. D., Shin, H., Freeman, G. J., Wherry, E. J. (2008). Selective expansion of a subset of exhausted CD8 T cells by {alpha}PD-L1 blockade. Proc. Natl. Acad. Sci. USA 105: 15016-15021 [Abstract] [Full Text]  
  • Das, A., Hoare, M., Davies, N., Lopes, A. R., Dunn, C., Kennedy, P. T.F., Alexander, G., Finney, H., Lawson, A., Plunkett, F. J., Bertoletti, A., Akbar, A. N., Maini, M. K. (2008). Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. JEM 205: 2111-2124 [Abstract] [Full Text]  
  • Brooks, D. G., Lee, A. M., Elsaesser, H., McGavern, D. B., Oldstone, M. B.A. (2008). IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. JEM 205: 533-541 [Abstract] [Full Text]  
  • Ha, S.-J., Mueller, S. N., Wherry, E. J., Barber, D. L., Aubert, R. D., Sharpe, A. H., Freeman, G. J., Ahmed, R. (2008). Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. JEM 205: 543-555 [Abstract] [Full Text]  
  • Watchmaker, P. B., Urban, J. A., Berk, E., Nakamura, Y., Mailliard, R. B., Watkins, S. C., van Ham, S. M., Kalinski, P. (2008). Memory CD8+ T Cells Protect Dendritic Cells from CTL Killing. J. Immunol. 180: 3857-3865 [Abstract] [Full Text]  
  • Radcliffe, J. N., Roddick, J. S., Stevenson, F. K., Thirdborough, S. M. (2007). Prolonged Antigen Expression following DNA Vaccination Impairs Effector CD8+ T Cell Function and Memory Development. J. Immunol. 179: 8313-8321 [Abstract] [Full Text]  
  • Holst, P. J., Bartholdy, C., Stryhn, A., Thomsen, A. R., Christensen, J. P. (2007). Rapid and sustained CD4+ T-cell-independent immunity from adenovirus-encoded vaccine antigens. J. Gen. Virol. 88: 1708-1716 [Abstract] [Full Text]  
  • Shin, H., Blackburn, S. D., Blattman, J. N., Wherry, E. J. (2007). Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. JEM 204: 941-949 [Abstract] [Full Text]  
  • Freeman, G. J., Wherry, E. J., Ahmed, R., Sharpe, A. H. (2006). Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade. JEM 203: 2223-2227 [Abstract] [Full Text]